Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer: Los Angeles Thursday, July 17, 2025, 15:00 Hrs [IST] Kairos Pharma, Ltd., a clini ...

Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharma company advancing cancer therapeutics, will participate in the H.C. Wainwright 27th ...

ASX bounced back with banks in charge, Aussie jobs data missed, and now all eyes are on a possible August RBA rate cut.

The S&P/ASX 200 closed 77.2 points higher, up 0.90%. In a nutshell: The ASX 200 hit its 10th record high of the year, reversing yesterday's 0.79% dip Market experienced a broad-based rally, with all ...